Magazine article Drug Topics

NSAIDs' Growing Role in Treating Arthritis

Magazine article Drug Topics

NSAIDs' Growing Role in Treating Arthritis

Article excerpt

By the end of 1994, Walgreen Co. plans to open seven stores simultaneously in Buffalo and surrounding communities. It's a new market for the chain, said Charles R. Walgreen III, chairman. "After our initial openings in Buffalo, we'll continue to open more stores to fill out the market."

NEW STUDENT PROFILE

Pharmacy school enrollment rose 4% last fall semester compared to the comparable period in 1991, according to AACP's "Profile of Pharmacy Students." The annual survey also found that 63.4% of the students were women, up 1.1%, and that 6,235 students were enrolled in Pharm.D. programs, up 6%.

CANCER FIGHTERS

A study conducted by the National Cancer Institute in Linxian, China, indicated that a combination of beta carotene, vitamin E, and selenium reduced the risk of dying from cancer. Some 30,000 men and women were included in the study; those who took the three nutrients for five years has a 13% lower incidence of cancer death than did those taking other nutrient combinations.

ZANTAC STILL GLAXO'S

A federal judge told Glaxo Inc. it still has patent protection for its antiulcer drug Zantac (ranitidine). The ruling prevents Novopharm Inc. from producing a generic version of the drug in 1995, the year when, according to Novopharm, Zantac's patent should expire. Novopharm said it will appeal the ruling.

MAHER MAN OF THE YEAR

David L. Maher, president and CEO, American Drug Stores, was named "Man of the Year" by the Retail Drug Institute of the Arnold & Marie Schwartz College of Pharmacy and Health Sciences at the Brooklyn Campus of Long Island University. Maher began as a pharmacist with Osco Drug. He became president-CEO of American Stores in 1985 when that company acquired Osco.

ANOTHER DEATH IN VACCINE TRIAL

A fifth person died at the end of August as a result of participating in a clinical trial of a new hepatitis B vaccine. The vaccine, fialuridine, has caused kidney, liver and nerve damage in seven of the 15 hepatitis patients who took it as part of the clinical trial conducted this past spring by the National Institutes of Health. …

Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.